The development of gene therapy and targeted therapy for prostate cancer has been a significant breakthrough in the treatment of the most prevalent malignancy in men, explained Seon Jo Park, PharmD, BCOP, a clinical pharmacy specialist at Allegheny Health of the Network Cancer Institute, during a session at the Hematology/Oncology Pharmacy Association 2021 Virtual Annual Conference.